← Back to patent-cliff list
CAS 182068-12-8
tert-butyl 2-{[(2-ethoxy-3-hydroxy-4-nitrophenyl)formamido]methyl}morpholine-4-carboxylate
Codes: Mosapride Citrate-058
Application context (from source-drug indications)
GastritisMosapride CitrateEnteral feeding intoleranceMosapride CitrateIrritable bowel syndromeMosapride CitrateDyspepsiaMosapride CitrateConstipationMosapride Citrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Mosapride Citrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-amino-5-chloro-2-ethoxy-3-hydroxy-N-[(5-oxomorpholin-2-yl)methyl]benzamide→4-amino-5-chloro-2-ethoxy-3-hydroxy-N-(morpholin-2-ylmethyl)benzamide→2,3-Dihydroxybenzaldehyde→2-ethoxy-3-hydroxybenzaldehyde→2-ethoxy-3-hydroxy-4-nitrobenzaldehyde→2-ethoxy-3-hydroxy-4-nitrobenzoic acid→6-(aminomethyl)morpholin-3-one→2-ethoxy-3-hydroxy-4-nitro-N-[(5-oxomorpholin-2-yl)methyl]benzamide→4-amino-2-ethoxy-3-hydroxy-N-[(5-oxomorpholin-2-yl)methyl]benzamide→2-ethoxy-3-hydroxy-4-nitrobenzoyl chloride→[4-(4-Fluorobenzyl)-2-morpholinyl]methylamine→2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)-3-hydroxy-4-nitrobenzamide→tert-butyl 2-{[(2-ethoxy-3-hydroxy-4-nitrophenyl)formamido]methyl}morpholine-4-carboxylate→tert-butyl 2-{[(4-acetamido-2-ethoxy-3-hydroxyphenyl)formamido]methyl}morpholine-4-carboxylate→tert-butyl 2-{[(5-chloro-4-acetamido-2-ethoxy-3-hydroxyphenyl)formamido]methyl}morpholine-4-carboxylate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.